| |
| |
|
| Insider
Information: |
Hanover Marc Steven |
| Relationship: |
Chief Executive Office... |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
124,362 |
|
|
Indirect Shares
|
47,687 |
|
|
| Direct
Value |
$42,606 |
|
|
|
Indirect Value
|
$16,338 |
|
|
| Total
Shares |
172,049 |
|
|
| Total
Value |
$58,944 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
Chief Executive Office... |
2018-01-05 |
124,362 |
2018-01-05 |
47,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Interim CEO, President and COO |
• • – |
2014-08-19 |
4 |
B |
$1.01 |
$8,448 |
D/D |
8,348 |
178,138 |
2.81 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
President and COO |
• • – |
2009-01-27 |
4 |
B |
$10.54 |
$21,080 |
D/D |
2,000 |
107,138 |
2.81 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
President and COO |
• • – |
2009-01-29 |
4 |
B |
$10.75 |
$10,747 |
D/D |
1,000 |
108,138 |
2.81 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • – |
2018-01-05 |
4 |
S |
$11.13 |
$82,845 |
D/D |
(7,309) |
124,362 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
President and COO |
• • – |
2004-11-10 |
5 |
D |
$11.83 |
$114,596 |
I/I |
(9,691) |
41,309 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
President and COO |
• • – |
2004-11-10 |
5 |
A |
$11.83 |
$114,596 |
D/D |
9,691 |
311,313 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • – |
2018-01-01 |
4 |
D |
$12.71 |
$81,306 |
D/D |
(6,397) |
131,671 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
President and COO |
• • – |
2007-03-14 |
4 |
S |
$22.10 |
$5,054,270 |
D/D |
(228,700) |
105,138 |
0 |
- |
|
33 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
